Experience
Medinol Ltd.
Abbott Laboratories
Finnegan client Abbott Laboratories's motion to enforce a settlement agreement with Medinol Ltd. was granted after the court adopted Abbott's interpretation of a settlement between the parties, which gave Abbott an unrestricted license to Medinol's stent patents. After a two-week jury trial on the validity of Medinol's remaining patent claims (but before the jury verdict was announced), the parties settled. When a disagreement arose over a material term during the drafting of the settlement agreement, Finnegan went back to court to enforce the agreement as the parties had stated on the record.
Medinol Ltd. v. Abbott Laboratories, 1:03-cv-02604, S.D.N.Y., Judges Francis, Scheindlin
Bruce N. Saffran, M.D., Ph.D. v. Abbott Laboratories
Abbott Laboratories
Abbott Laboratories v. Sandoz Inc.
Abbott Laboratories
Coronary Stent Visualization Corp. v. Philips Electronic North America Corp.
Philips Electronic North America Corp.
Abbott Laboratories v. Teva Pharmaceuticals USA, Inc.
Abbott Laboratories
Hybritech Inc. v. Abbott Laboratories
Hybritech Inc.
Guidant Corp.
A victory at trial for innovator of cardiovascular stents
Abbott Laboratories
Medtronic Vascular Inc. v. Abbott Vascular, Inc.
Abbott Vascular, Inc.
Due to international data regulations, we’ve updated our privacy policy. Click here to read our privacy policy in full.
We use cookies on this website to provide you with the best user experience. By accepting cookies, you agree to our use of cookies. Please note that if you opt not to accept or if you disable cookies, the “Your Finnegan” feature on this website will be disabled as well. For more information on how we use cookies, please see our Privacy Policy.
Finnegan is thrilled to announce the launch of our new blog, Ad Law Buzz, devoted solely to breaking news, developments, trends, and analysis in advertising law.